The Biden White House has brokered a deal between Johnson & Johnson and Merck that will have the latter company produce additional supplies of the recently approved J&J vaccines. The Post reports that the President will use the Defense Production Act to give Merck priority in purchasing equipment to ramp up for production.
Members-Only ArticleAll Cylinders
Members-Only Article
Already a member? Sign In
To access exclusive analysis and reporting from TPM’s award-winning staff along with:
The Hive Member Forum
Members-Only Newsletter
Exclusive RSS Feeds
Commenting
Prime
$60/yr
Access to member exclusives and fewer ads
Get Prime
Prime Ad Free
$100/yr
Access to member exclusives and NO ads
Get Prime AF